Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

25,383 total articles

Standard Nuclear Files for US IPO to Raise Up to $383.25 Million

Standard Nuclear Files for US IPO to Raise Up to $383.25 Million

Standard Nuclear has filed to sell 18,250,000 shares of Class A common stock in a U.S. initial public offering, targeting gross proceeds of as much as $383.25 million. The company, which makes tristructural-isotropic (TRISO) and high-assay low-enriched uranium (HALEU) fuels for small modular reactors, has applied to list its Class A shares on the N…

NATO Chooses Saab GlobalEye to Replace AWACS in Multi-Billion Dollar Program

NATO Chooses Saab GlobalEye to Replace AWACS in Multi-Billion Dollar Program

NATO has announced plans to acquire up to 10 Saab GlobalEye surveillance aircraft in a program valued at roughly $4.5 billion to replace aging E-3 AWACS early warning planes. The alliance selected the Swedish GlobalEye over Boeing’s competing E-7 Wedgetail, saying the business-jet based system will strengthen detection capabilities against modern t…

NATO Opens Negotiations with Saab for Up to Ten GlobalEye AEW&C Systems

NATO Opens Negotiations with Saab for Up to Ten GlobalEye AEW&C Systems

NATO has entered formal negotiations with Saab to potentially acquire up to ten GlobalEye Airborne Early Warning & Control platforms, Secretary General Mark Rutte said at the NATO summit in Ankara, Türkiye. No contract has been signed and Saab has not received an order. The move is part of NATO's effort to modernize its airborne surveillance and si…

Teva Advances Anti-IL-15 Antibody TEV-’408 to Phase 2b for Vitiligo After Encouraging Phase 1b Readout

Teva Advances Anti-IL-15 Antibody TEV-’408 to Phase 2b for Vitiligo After Encouraging Phase 1b Readout

Teva Pharmaceutical Industries said it will move its investigational anti-interleukin-15 monoclonal antibody, TEV-’408, into a Phase 2b study for vitiligo in the fourth quarter of 2026. The decision follows results from an open-label Phase 1b trial in adults with active or stable non-segmental vitiligo that reported measurable gains in pigmentation…

Standard Nuclear Begins IPO Roadshow, Targets $18 to $21 Per Share

Standard Nuclear Begins IPO Roadshow, Targets $18 to $21 Per Share

Standard Nuclear, Inc. has kicked off its initial public offering roadshow offering 18,250,000 Class A shares at an expected price range of $18.00 to $21.00 per share. The company has applied to list on the New York Stock Exchange under the symbol STDN, granted underwriters a 30-day option for additional shares, and named major banks as bookrunning…

Barclays Sees Small Earnings Impact from Potential ECB Reserve Hike

Barclays Sees Small Earnings Impact from Potential ECB Reserve Hike

Barclays analysts estimate that a hypothetical increase in the European Central Bank's minimum reserve requirement from 1% to 2% would have a modest effect on bank earnings and net interest income in 2027, but the firm regards such a policy move as unlikely. The ECB's discussions are at an early stage with a formal decision expected by autumn befor…

DeepSeek Moves to Build Its Own AI Chip, Pressuring Nvidia Shares

DeepSeek Moves to Build Its Own AI Chip, Pressuring Nvidia Shares

A report on Tuesday said DeepSeek is developing a custom semiconductor for AI inference workloads, a project that could reduce its reliance on Nvidia and Huawei chips. Nvidia shares dipped 1.6% in premarket trading by 06:59 ET (10:59 GMT) after the report. The effort, which dates back about a year, is still at an early stage but has involved discus…

TotalEnergies CEO Holds Talks in Damascus on Potential Exploration Deal

TotalEnergies CEO Holds Talks in Damascus on Potential Exploration Deal

TotalEnergies Chief Executive Patrick Pouyanne met with Syrian authorities in Damascus to discuss progressing from an initial memorandum of understanding toward a formal exploration contract. The talks took place before explosions were reported in the city center. Pouyanne said teams cannot be sent to onshore sites until the Syrian government estab…